US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aequus Pharmaceuticals Inc.

0.0049

0.0000

Volume:- -

Turnover:- -

Market Cap:652.56K

PE:-0.43

High:0.0049

Open:0.0049

Low:0.0049

Close:0.0049

52wk High:0.0080

52wk Low:0.0001

Shares:132.63M

Float Shares:112.80M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0113

EPS(LYR):-0.0114

ROE:-1569.60%

ROA:-68.07%

PB:-0.13

PE(LYR):-0.43

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Aequus Pharmaceuticals Inc.

Exchange:

PINK LIMITED

Establishment Date:

2013

Employees:

- -

Office Location:

200 Granville Street,Suite 2820,Vancouver,British Columbia,Canada

Website:

http://www.aequuspharma.ca

Zip Code:

V6C 1S4

Phone:

Fax:

- -

Introduction:

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AQSZF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AQSZF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AQSZF\",,,,,undefined,":{"symbol":"AQSZF","market":"US","secType":"STK","nameCN":"Aequus Pharmaceuticals Inc.","latestPrice":0.00492,"timestamp":1771954260000,"preClose":0.00492,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":112795463,"shares":132634431,"eps":-0.011333,"marketStatus":"Trading","change":0,"latestTime":"02-24 12:31:00 EST Delay","open":0.00492,"high":0.00492,"low":0.00492,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.011333,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":0.00492,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AQSZF\",,,,,undefined,":{"symbol":"AQSZF","floatShares":112795463,"roa":"-68.07%","roe":"-1569.60%","lyrEps":-0.011411,"shares":132634431,"dividePrice":0,"high":0.00492,"amplitude":0,"preClose":0.00492,"low":0.00492,"week52Low":0.0001,"pbRate":"-0.13","psRate":"0.97","week52High":0.008,"institutionHeld":0,"latestPrice":0.00492,"eps":-0.011333,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.011333,"open":0.00492,"prevYearClose":0.002,"prevWeekClose":0.0066,"prevMonthClose":0.002,"prevQuarterClose":0.002,"fiveDayClose":0.008,"twentyDayClose":0.002,"sixtyDayClose":0.0012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AQSZF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-09","symbol":"AQSZF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-29","symbol":"AQSZF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1701234000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-29","symbol":"AQSZF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1693281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-05-30","symbol":"AQSZF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1685419200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-05-01","symbol":"AQSZF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1682913600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AQSZF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AQSZF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":247433914,"yearFounded":2013,"address":"200 Granville Street,Suite 2820,Vancouver,British Columbia,Canada","zipCode":"V6C 1S4","officePhone":"604 336 7906"},"stockCompanyDetail":{"websiteUrl":"http://www.aequuspharma.ca","stockEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":-0.0648},{"period":"3month","weight":-0.2519},{"period":"6month","weight":-0.2885},{"period":"1year","weight":-0.2622},{"period":"ytd","weight":-0.1062}],"description":"Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.","exchange":"PINK LIMITED","name":"Aequus Pharmaceuticals Inc.","nameEN":"Aequus Pharmaceuticals Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AQSZF\",market:\"US\",,,undefined,":null}}